Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2021.

 SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday, July 26, 2021, to inter alia consider and approve, the unaudited financial results of the Company for the quarter ended June 30, 2021. Further, kindly note that pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons, shall remain closed upto 48 hours after the declaration of financial results of the Company on July 26, 2021.
17-07-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021
14-07-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilip S Shanghvi
09-07-2021

SPARC raises Rs 1,110 cr, issues warrants to promoter Dilip Shanghvi, others

 The issue price includes the warrant subscription price (Rs. 44.50 per warrant) and the warrant exercise price (Rs. 133.50 per warrant). The company had initially planned to raise Rs 1,200 crore
08-07-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Allotment

 the Securities Allotment Committee of the Board of Directors of the Company, has considered and approved the Allotment of 6,24,74,082 (Six Crore Twenty Four Lakhs Seventy Four Thousand and Eighty Two) warrants on preferential basis at an issue price [including the warrant subscription price (Rs. 44.50 per warrant) and the warrant exercise price (Rs. 133.50 per warrant)] of Rs. 178/- each (Rupees One Hundred and Seventy Eight only) aggregating to Rs. 1112,03,86,596 (Rupees One Thousand One Hundred Twelve Crore Three Lakhs Eighty Six Thousand Five Hundred and Ninety Six only), to Mr. Dilip Shantilal Shanghvi, Promoter of the Company and to certain other non-promoter persons/ entities ('Allottees') (as per the list enclosed marked as Annexure I).
08-07-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Dear Sir/ Madam, We refer to our letter dated 24th June 2021 vide which we had submitted the 'Annual Secretarial Compliance Report' ('Audit Report') of the Company for the year ended 31st March 2021 issued by KJB & Co. LLP, Practicing Company Secretaries, Mumbai. It was observed that, due to some technical glitch, the unsigned copy of the said Audit Report got uploaded instead of the signed copy. Considering the above, we are now enclosing the signed copy of the Audit Report. It may please be noted that both the Audit Report(s) are same, except that the current Audit Report enclosed herewith is a signed copy. We sincerely regret the inconvenience caused and request you to take on record the enclosed signed copy of the Audit Report.
30-06-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Closure of Trading Window

 This is to inform you that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company's Code of Conduct for Prevention of Insider Trading ('The CoC'), the Trading Window for trading by Designated Persons of the Company and their immediate relatives will be closed with effect from Thursday, 1st July 2021 till 48 hours after the declaration of financial results of the Company for the quarter ending 30th June 2021. The date of Board Meeting for declaration of the financial results for the quarter ending 30th June 2021 will be intimated in due course.
29-06-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMDl/27/2019 dated February 08, 2019, please find enclosed, the 'Annual Secretarial Compliance Report' of the Company for the year ended 31st March 2021 issued by KJB & Co. LLP, Practicing Company Secretaries, Mumbai. We request you to kindly take the same on record.
24-06-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Sun Pharma Advanced Research Company Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
10-06-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosure Of Scrutinizer'S Consolidated Report (Including Majority As Per Regulation 23(4) Of SEBI LODR Regulations) For Remote E-Voting And E-Voting At The Extra Ordinary General Meeting Of The Company Held On 8Th June, 2021 Through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM').

 Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit herewith the details of the result of remote e-voting as well as e-voting conducted at the Extra-Ordinary General Meeting (EGM) of Sun Pharma Advanced Research Company Limited held on 8th June, 2021 from 04:00 p.m. to 04:40 p.m. through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM') in respect of all the resolutions as set out in the Notice dated 12th May 2021, for your information and dissemination.
10-06-2021
Next Page
Close

Let's Open Free Demat Account